October 23, 2013
Peanut butter and a ruler may turn out to be tools that offer an inexpensive, sensitive, and specific olfactory means of screening for Alzheimer disease. Details here.
October 17, 2013
The real impact of nutritious menu changes at fast food chains like McDonalds remains to be seen, but these-along with modifying the dosage schedules of patients who appear to be statin-intolerant-may prove to have long-term salubrious effects.
October 04, 2013
A new study finds that intermittent dosing of a statin can be an effective treatment option for some patients who previously demonstrated intolerance to statins.
April 09, 2013
Here: how omega-3 fatty acids may help reduce the risk of atrial fibrillation (AF) in postcardiac surgery patients; how incident HF can help predict adverse outcomes in patients with AF; and why an old gout drug may help reduce the risk of AF in patients with heart failure.
March 15, 2013
PREVAIL study of Watchman left atrial appendage closure device confirms device safety and meets primary safety endpoint.
March 15, 2013
The strategy of catheter ablation–based rhythm control in patients with long-standing persistent atrial fibrillation (AF) plus heart failure (HF) was found superior to pharmacologic rate control for improving cardiopulmonary exercise capacity, quality of life, and neurohormonal status in this small, randomized study.
February 14, 2013
Atrial fibrillation can do a great deal of damage. This is a reality that those who regularly drink more than moderately need to be made aware of.
February 13, 2013
Something new to worry about: this study shows that atrial fibrillation is independently associated with increased risk of dementia.
January 30, 2013
Dark chocolate, tomatoes, and grapeseed oil are just a few of the natural approaches to cardiovascular risk reduction supported by science.
January 02, 2013
Here: the story of how cocaine was discovered by the Europeans and Americans, how it affected two giants of medicine-and how it played a key role in Detroit's economy and in the formation of what was once one of the world's biggest pharmaceutical companies.